<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2305233696
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2017
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        AERRANE LIQUID FOR INHALATION
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ISOFLURANE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Inhalation use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Inhalation vapour, liquid
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        6
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        406.50
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="BAXTER HEALTHCARE" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            BAXTER HEALTHCARE
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 416]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Arabian Health Care Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            BAXTER HEALTHCARE CORPORATION
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N01AB06
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>AErrane contains isoflurane. AErrane is a general anaesthetic used in surgery. It is an inhalation anaesthetic (it is given to you as a vapour for you to breathe in). Breathing in isoflurane vapour causes you to fall into a deep, painless sleep. It also maintains a deep, painless sleep (general anaesthesia) during which you can undergo surgery.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Your doctor will not give you </strong><strong>AErrane if:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you are allergic (hypersensitive) to isoflurane or other inhalation anaesthetics such as desflurane, sevoflurane, halothane and enflurane.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you, or any relative suffer from a condition called malignant hyperthermia. Malignant hyperthermia is when you suddenly develop a dangerously high body temperature during or shortly after surgery.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; following anaesthesia with AErrane or other inhalation anaesthetics (e.g. desflurane, sevoflurane, halothane) in the past, you have had unexplained liver problems with:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; jaundice (yellowing of the skin and white of the eyeballs)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased levels of white blood cells called leucocytes (leucocytosis)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased levels of a certain type of white blood cells called eosinophils (eosinophilia).</p><p>You must not be given AErrane for operations during pregnancy, childbirth or the period just after childbirth. AErrane may, however, be used for a Caesarean section.</p><p>&nbsp;</p><p>If any of the above applies to you, please inform your doctor, surgeon or anaesthetist before you are treated with this medicine.</p><p>&nbsp;</p><p><strong>Warnings and Precautions</strong></p><p>&nbsp;</p><p>Talk to your doctor, nurse or pharmacist before being given AErrane.</p><p>&nbsp;</p><p><strong>Your doctor will take special care with this medicine if: </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have a disorder of the cells (a condition called mitochondrial disorder)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you suffer from liver problems such as:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hepatitis (inflamed liver)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cirrhosis of the liver (replacement of healthy liver tissue with scar tissue). This can happen if you drink too much alcohol</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; any other liver disease</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have recently had an operation for which you received general anaesthesia with an inhalation anaesthetic</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you are suffering from the symptoms of any illness other than those connected with your operation, such as severe headaches, nausea, vomiting, severe chest pain or a condition that affects muscles (a neuromuscular disease e.g. Duchenne muscular dystrophy or myasthenia gravis).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you suffer with bronchoconstriction (a tightening of the lungs and airways leading to coughing, wheezing or shortness of breath).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;The patient is a child under two years of age.</p><p>&nbsp;</p><p><strong>Your doctor may give you less AErrane if:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have a low blood volume (hypovolaemia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have low blood pressure (hypotension)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you are weakened (debilitated)</p><p>&nbsp;</p><p>AErrane can cause irritation of the lining of the mouth and the airways, which may result in an increased saliva flow and increased slime production from the windpipe and upper airways. In children this may make it harder for them to breathe in or can cause a muscle spasm of the vocal chords (voicebox) called a laryngospasm.</p><p>&nbsp;</p><p>If you are having an abortion you may suffer increased loss of blood if you are given AErrane.</p><p>&nbsp;</p><p><strong>If you are given AErrane, you may have brief:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in liver function</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increases in blood sugar (glucose) levels</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decreases in blood levels of a fat called cholesterol</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in blood enzyme levels</p><p>&nbsp;</p><p>AErrane can cause malignant hyperthermia (when you suddenly develop a dangerously high body temperature during or shortly after surgery). Fatal outcome of malignant hyperthermia has been reported with AErrane.</p><p>&nbsp;</p><p><strong>Your doctor will monitor your breathing during treatment, especially if you are given any other medicines which can affect your breathing, like:</strong><br />&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sedatives (e.g. diazepam, nitrazepam)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; strong pain killers (e.g. opioids such as fentanyl, morphine and remifentanil)</p><p>&nbsp;</p><p><strong>Children</strong> Rarely, inhaled anaesthetics can cause problems with heart rhythm in children. This can result in death in the period immediately after the operation. These problems are seen in children that suffer from a disease of the nerves and muscles (neuromuscular disease), particularly a disease called &lsquo;Duchenne muscular dystrophy&rsquo;. In most, but not all of these cases a muscle relaxant named succinylcholine was given at the same time.</p><p>&nbsp;</p><p>If children are given AErrane to bring on (induce) anaesthesia this can cause unwanted side effects such as:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased saliva flow</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased secretions in the windpipe and upper airways</p><p>&nbsp;</p><p>These can cause a muscle spasm of the vocal chords (voicebox) called a laryngospasm. If any of the above apply to you or your child, check with your doctor, nurse or pharmacist.</p><p>You may need to be checked carefully and your treatment may be changed.</p><p>&nbsp;</p><p><strong>Other medicines and AErrane: </strong></p><p>&nbsp;</p><p>Tell your doctor, nurse or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines that you have obtained yourself, without a prescription, including herbal medicines and natural products.&nbsp;</p><p>&nbsp;</p><p>You must take special care if you are also taking any of the following medicines:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; non selective MAOIs (monoamine oxidase inhibitor such as phenelzine, isocarboxazid): Your doctor will instruct you to stop taking such medicines 15 days before you have your operation.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart medicines called beta-sympathomimetics (e.g. isoprenaline) and alpha- and beta-sympathomimetics (e.g. adrenaline, noradrenaline): These may cause a serious irregular heartbeat.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; beta-blockers (e.g. atenolol, metoprolol): These are heart medicines often given to treat a high blood pressure.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; isoniazid: A medicine used to treat tuberculosis (TB). Your doctor will instruct you to stop using isoniazid one week before your operation. Do not start taking isoniazid again until 15 days after your operation.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; indirect sympathomimetic drugs e.g.:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; amphetamines, amphetamine derivatives (used to treat attention-deficit hyperactivity disorder (ADHD))</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; drugs which reduce your appetite</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ephedrine and ephedrine derivatives (commonly found in cough and cold medicines)</p><p>These medicines may cause an increased risk of high blood pressure when given together with Aerrane. Your doctor will instruct you if and when to stop these medicines.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; muscle relaxants (e.g. suxamethonium, pancuronium, atracurium, vecuronium). These medicines are used during general anaesthesia to relax your muscles. Your anaesthetist may need to reduce the dose of these medicines.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; opioids (e.g. morphine, fentanyl, remifentanil): These medicines are strong pain killers and are often used during general anaesthesia.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; calcium antagonists: Used for treating high blood pressure (e.g. felodipine, nicardipine)</p><p>&nbsp;</p><p><strong>AErrane with food and drink</strong></p><p>&nbsp;</p><p>Aerrane is a medicine to make and keep you asleep so you can undergo surgery. You should ask your doctor, surgeon or anaesthetist when and what you can eat or drink after you wake up.</p><p>You should not drink alcohol. Your doctor will tell you when you can resume drinking alcohol.</p><p>&nbsp;</p><p><strong>Pregnancy and breast-feeding</strong></p><p>&nbsp;</p><p>You will only be given AErrane whilst you are pregnant if the benefit outweighs the risk, as there is limited data of use in pregnant women. However, lower doses of AErrane can be used during Caesarean section.<br />&nbsp;</p><p>As it is not known if AErrane is excreted in human milk, you should avoid breast feeding after an operation if you were given AErrane as the general anaesthetic.</p><p>&nbsp;</p><p>Consult your doctor, surgeon or anaesthetist if you are pregnant, might be pregnant, or if you are breast-feeding.</p><p>&nbsp;</p><p><strong>Driving and using machines</strong></p><p>&nbsp;</p><p>Do not drive or operate tools or machines for at least 24 hours after your operation if you were given AErrane. Receiving an anaesthetic may influence your alertness and behaviour which may affect your ability to carry out normal tasks for up to 6 days. Make sure that someone takes you home after your operation.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>AErrane will ALWAYS be administered to you by an anaesthetist. They will decide on the dose you will receive, depending on your age, weight and the type of operation you are having.</p><p>&nbsp;</p><p>Your child should be monitored closely during the administration of Isoflurane.</p><p>&nbsp;</p><p><u>Inducing sleep at the start of anaesthesia </u></p><p>Isoflurane is not recommended in infants and children for inducing sleep at the start of anaesthesia.</p><p>&nbsp;</p><p><u>Medication before anaesthesia </u></p><p>The anaesthetist may decide to give your child medication to counteract the possible reduction in breathing and heart rate effects which may occur with the use of Isoflurane.</p><p>&nbsp;</p><p>AErrane is produced from liquid isoflurane in a vaporiser. You may receive AErrane in one of two ways:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you may be given an injection of another anaesthetic to make you sleep before being given AErrane through a mask. This is the most common way that you may receive AErrane.</p><p>Or</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you may be asked to breathe the isoflurane vapour through a mask to make you sleep. You will fall asleep quickly and very easily. This is a less common way to receive AErrane.</p><p>&nbsp;</p><p>After your surgery, your anaesthetist will stop giving you AErrane. You will then wake up in a few minutes.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>If you have too much AErrane </strong></p><p>&nbsp;</p><p>If you are given too much AErrane the medicine will be stopped. You will be given pure oxygen. Your blood pressure and heart function will be carefully checked while you recover.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them Most side effects are mild to moderate in their severity and are brief but there may be some serious side effects.</p><p>&nbsp;</p><p>If you or your child suffer from any unusual or unexpected symptoms after an operation tell your doctor or anaesthetist IMMEDIATELY.</p><p>&nbsp;</p><p>The most commonly reported side effects are:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A tightening of your lungs and airways causing a difficulty in breathing</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increases in blood sugar levels or potassium levels. There have been rare reports of abnormal heartbeat (arrhythmias) and death associated with the use of inhaled anaesthetics in children shortly after surgery</p><p>&nbsp;</p><p><strong>Tell your doctor, nurse or pharmacist straight away if you notice any of the following side effects, which can be serious.</strong></p><p>&nbsp;</p><p><strong>Not known (the number of people affected is unknown)</strong></p><ul><li>Presence of carboxyhaemoglobin in the blood</li><li>Allergic reaction</li><li>Hypersensitivity</li><li>Agitation, alterations in mood, sometimes extreme</li><li>Confusion, convulsions, mental impairment</li><li>Irregular heart beat or palpitations</li><li>Abnormal electrocardiogram (ECG), change in heart rate or rhythm</li><li>Cardiac arrest</li><li>Low blood pressure</li><li>Haemorrhage (uncontrolled bleeding)</li><li>Slow shallow breathing</li><li>Shortness of breath, wheezing</li><li>A muscle spasm of the vocal chords (voice box) called a laryngospasm</li><li>Swelling of the face</li><li>Contact dermatitis</li><li>Skin rash</li><li>Increased blood levels of an enzyme called creatinine</li><li>Decreased blood levels of a substance called urea</li><li>Muscles of your intestine may stop working temporarily, causing discomfort, bloating and vomiting</li><li>Nausea and vomiting</li><li>Inability of the liver to function properly, including liver injury, liver cell death</li><li>Increased blood levels of a substance called bilirubin</li><li>Shivering, chills</li><li>Raised body temperature due to malignant hyperthermia</li><li>Chest discomfort</li><li>Abnormal levels of certain cells or products found in your blood</li><li>Increases in blood fluoride levels (due to your body breaking down isoflurane) Abnormal results from a EEG (electroencephalogram) test</li><li>Presence of myoglobin (material from the muscles) in the urine</li><li>Muscle destruction</li></ul><p>&nbsp;</p><p><strong>Reporting of suspected adverse reactions</strong></p><p>&nbsp;</p><p>If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via:</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia:</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:621px"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance Centre (NPC)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa/</p></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp; <strong>Other GCC States:</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:621px"><tbody><tr><td><p>-&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p></td></tr></tbody></table><p>&nbsp;</p><p>By reporting side effects you can help provide more information on the safety of this medicine</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Store below 30&deg;C.</p><p><strong>&nbsp;</strong></p><p>Keep out of sight and reach of children.</p><p>&nbsp;</p><p>Do not use AErrane after the expiry date that is printed on the label. The expiry date refers to the last day of that month.</p><p>&nbsp;</p><p>Do not throw any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. &nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What AErrane contains</strong></p><p>&nbsp;</p><p>The active substance is isoflurane.</p><p>There are no other ingredients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                AErrane is a liquid.
It is supplied in 100 ml bottles with screw cap closures.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>MARKETING AUTHORISATION HOLDER</strong></p><p><strong>Baxter Healthcare Corporation </strong></p><p>Deerfield</p><p>IL 60015</p><p>USA</p><p><strong>&nbsp;</strong></p><p><strong>MANUFACTURER</strong></p><p><strong>Baxter Healthcare Corporation </strong></p><p>Route 3 Km 142.5</p><p>00784 Guayama</p><p>Puerto Rico</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                October 2017
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي دواء إيرين على مادة الأيزوفلوران. ويعد إيرين مخدرًا عامًا يستخدم في العمليات الجراحية. كما أنه عبارة عن مخدر يتم تناوله بالاستنشاق (يعطى لك في صورة بخار يتم استنشاقه). ويتسبب استنشاق بخار الأيزوفلوران في نوم عميق غير مؤلم. كما أنه يحافظ على توفير نوم عميق غير مؤلم (تخدير عام) يمكنك خلاله الخضوع لعملية جراحية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لن يقوم طبيبك بإعطائك إيرين في </strong><strong>الحالات التالية:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حساسية (حساسية شديدة) تجاه مادة الأيزوفلوران أو أدوية التخدير الأخرى التي يتم إعطاؤها عبر الاستنشاق مثل ديسفلوران وسيفوفلوران وهالوثان وإنفلوران.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني، أو أحد أقاربك، من حالة مَرضية تسمى فرط الحرارة الخبيث. ويحدث فرط الحرارة الخبيث عندما تصاب فجأة بارتفاع خطير في درجة حرارة الجسم أثناء العملية الجراحية أو بعدها بفترة قصيرة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا تعرضت بعد التخدير باستخدام إيرين أو غيره من المواد المخدرة عبر الاستنشاق (مثل ديسفلوران، وسيفوفلوران، وهالوثان) في الماضي لمشكلات غير مبررة في الكبد مع:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اليرقان (اصفرار الجلد وبياض مقلة العين)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحمى</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة مستويات خلايا الدم البيضاء التي تسمى الكريات البيضاء (زيادة عدد الكريات البيضاء)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة مستويات نوع محدد من خلايا الدم البيضاء التي تسمى اليوزينيات (زيادة عدد اليوزينيات).</p><p dir="RTL">يجب ألا يتم إعطاؤك دواء إيرين لإجراء عمليات جراحية أثناء الحمل أو الولادة أو الفترة التي تلي الولادة مباشرة. ومع ذلك، يمكن استخدام دواء إيرين لإجراء عملية قيصرية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كانت أي من الحالات المذكورة أعلاه تنطبق عليك، يرجى إخبار طبيبك أو الجراح أو طبيب التخدير قبل أن يتم إعطاؤك هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التحذيرات والاحتياطات</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">تحدث إلى طبيبك أو الممرضة أو الصيدلي قبل إعطاؤك إيرين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>سيتوخى طبيبك الحذر الشديد عند إعطائك هذا الدواء في الحالات التالية: </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من اضطراب في الخلايا (حالة تسمى اضطراب الميتوكوندريا)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشكلات في الكبد مثل:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الكبد (كبد ملتهب)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تليف الكبد (استبدال أنسجة الكبد السليمة بنسيج ندبي). ويمكن أن يحدث ذلك إذا كنت تتناول كميات كبيرة من الكحول</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أي مرض كبدي آخر</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت خضعت مؤخرًا لعملية جراحية تلقيت فيها تخديرًا عامًا باستخدام مخدر بالاستنشاق</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من أعراض أي مرض غير المرتبطة بالعملية الجراحية، مثل الصداع الشديد والغثيان والقيء وألم شديد في الصدر أو حالة مَرضية تؤثر في العضلات (مرض عصبي عضلي مثل الحثل العضلي الدوشيني أو الوهن العضلي الوبيل).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من تضيق قصبي (تضيق في الرئتين والمسالك الهوائية يؤدي إلى سعال أو صفير أو ضيق في التنفس).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;إذا كان المريض طفلًا دون سن عامين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>ربما يقوم طبيبك بإعطائك القليل من دواء إيرين في الحالات التالية:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك انخفاض في حجم الدم (نقص حجم الدم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من انخفاض ضغط الدم (نقض ضغط الدم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت ضعيف الجسم (مُنهك القوى)</p><p dir="RTL">&nbsp;</p><p dir="RTL">يمكن أن يسبب إيرين تهيجًا في بطانة الفم والمسالك الهوائية، ما قد يؤدي إلى زيادة تدفق اللعاب وزيادة إنتاج المادة اللعابية اللزجة من القصبة الهوائية والمسالك الهوائية العليا. وبالنسبة إلى الأطفال، قد يؤدي ذلك إلى صعوبة التنفس أو قد يتسبب في تشنج عضلي في الأحبال الصوتية (الحنجرة) يسمى تشنج الحنجرة.</p><p dir="RTL">إذا كنتِ تخضعين لعملية إجهاض، فقد تعانين من فقدان متزايد للدم إذا تم إعطاؤك دواء إيرين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا تم إعطاؤك دواء إيرين، فربما تعاني لفترة قصيرة من الآتي:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في وظائف الكبد</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة مستويات السكر (الجلوكوز) في الدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض مستويات الدهون في الدم الذي يسمى الكوليسترول</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في مستويات إنزيمات الدم</p><p dir="RTL">&nbsp;</p><p dir="RTL">يمكن أن يتسبب دواء إيرين في الإصابة بفرط الحرارة الخبيث (عندما تصاب فجأة بارتفاع خطير في درجة حرارة الجسم أثناء العملية الجراحية أو بعدها بفترة قصيرة). وتم الإبلاغ عن نتيجة مميتة لفرط الحرارة الخبيث الناجم عن استخدام دواء إيرين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>سيراقب طبيبك التنفس أثناء العلاج، خاصة إذا كنت تتناول أي أدوية أخرى يمكن أن تؤثر في تنفسك، مثل:</strong><br />&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المهدئات (مثل ديازيبام، نيترازيبام)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مسكنات الألم القوية (مثل المواد الأفيونية مثل الفنتانيل والمورفين والريميفنتانيل)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأطفال</strong> في حالات نادرة، يمكن أن تتسبب الأدوية المخدرة المتناولة بالاستنشاق في مشكلات في نظم القلب لدى الأطفال. ويمكن أن يؤدي ذلك إلى الوفاة خلال الفترة التي تلي العملية الجراحية مباشرة. كما أن هذه المشكلات تظهر لدى الأطفال الذين يعانون من مرض في الأعصاب والعضلات (مرض عصبي عضلي)، خاصة المرض الذي يسمى &quot;الحثل العضلي الدوشيني&quot;. لذلك في معظم الحالات وليس جميعها، يتم إعطاء مُرخٍ للعضلات يسمى &quot;سكسينيل كولين&quot; في الوقت نفسه.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا تم إعطاء الأطفال دواء إيرين بهدف (تحفيز) التخدير، فقد يتسبب ذلك في آثار جانبية غير مرغوب فيها مثل:</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة تدفق اللعاب</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة الإفرازات في القصبة الهوائية والمسالك الهوائية العليا</p><p dir="RTL">&nbsp;</p><p dir="RTL">يمكن أن تؤدي هذه الآثار الجانبية إلى تشنج عضلي في الأحبال الصوتية (الحنجرة) يسمى تشنج الحنجرة. لذلك، &rlm;‫إذا انطبقت عليك أو على طفلك أي من الحالات المذكورة أعلاه، فارجع إلى طبيبك أو الممرضة أو الصيدلي. فقد تحتاج إلى أن يتم فحصك بعناية وقد يتم تغيير العلاج.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأدوية الأخرى ودواء إيرين: </strong></p><p dir="RTL">أخبر طبيبك أو الممرضة أو الصيدلي إذا كنت تتناول أو تناولت مؤخرًا أو قد تتناول أي أدوية أخرى. وهذا يشمل الأدوية التي حصلت عليها بنفسك، دون وصفة طبية، بما في ذلك الأدوية العشبية والمنتجات الطبيعية.&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب أن تنتبه جيدًا إذا كنت أيضًا تتناول الأدوية التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مثبطات أكسيداز أحادي الأمين (MAOI) غير الانتقائية (مثبطات MAOI مثل فينيلزين، وإيزوكاربوكسازيد): سيوجهك طبيبك للتوقف عن تناول هذه الأدوية قبل 15 يومًا من إجراء العملية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية القلب التي تسمى محاكيات بيتا الودية (مثل إيزوبرينالين) ومحاكيات ألفا وبيتا الودية (مثل الأدرينالين والنورادرينالين): قد تسبب هذه الأدوية عدم انتظام خطير في ضربات القلب.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حاصرات بيتا (مثل أتينولول، ميتوبرولول): يتم إعطاء أدوية القلب هذه لعلاج ارتفاع ضغط الدم في الغالب.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أيزونيازيد: دواء يستخدم لعلاج السل (TB) سيوصي طبيبك بالتوقف عن استخدام أيزونيازيد قبل موعد إجراء العملية بأسبوع. لا تبدأ في تناول أيزونيازيد مرة أخرى حتى مرور 15 يومًا بعد العملية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المحاكية الودية غير المباشرة مثل:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأمفيتامينات ومشتقات الأمفيتامين (تستخدم لعلاج اضطراب نقص الانتباه وفرط النشاط (ADHD))</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تضعف الشهية</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإيفيدرين ومشتقات الإيفيدرين (توجد عادة في أدوية السعال والبرد)</p><p dir="RTL">قد تتسبب هذه الأدوية في زيادة خطر الإصابة بارتفاع ضغط الدم عند تناولها مع دواء إيرين. سيخبرك طبيبك إذا كان ينبغي أن تتوقف عن تناول هذه الأدوية ومتى تتوقف عن تناولها.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المرخية للعضلات (مثل سوكساميثونيوم، وبانكورونيوم، وأتراكوريوم، وفيكورونيوم). تستخدم هذه الأدوية أثناء التخدير العام لإرخاء عضلاتك. وقد يحتاج طبيب التخدير إلى تقليل جرعة هذه الأدوية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المواد الأفيونية (مثل المورفين والفنتانيل والريميفنتانيل): تعد هذه الأدوية مسكنات قوية للألم وغالبًا ما تستخدم أثناء التخدير العام.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مضادات الكالسيوم: تستخدم لعلاج ارتفاع ضغط الدم (مثل فيلوديبين، ونيكارديبين).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>دواء إيرين مع الأطعمة والمشروبات</strong></p><p dir="RTL">دواء إيرين يمكنك من الاستغراق في النوم حتى تتمكن من الخضوع لعملية جراحية. يجب أن تسأل طبيبك أو الجراح أو طبيب التخدير عن الأطعمة والمشروبات التي يمكن تناولها ومواعيدها بعد الاستيقاظ. وينبغي ألا تتناول الكحول. وسيخبرك طبيبك عن موعد استئناف تناول الكحول.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة</strong></p><p dir="RTL">سيتم إعطاؤك دواء إيرين أثناء الحمل إذا كانت الفوائد تفوق المخاطر فقط، نظرًا إلى وجود بيانات محدودة لاستخدامه مع النساء الحوامل. ومع ذلك، يمكن استخدام جرعات منخفضة من إيرين أثناء إجراء عملية قيصرية.<br />&nbsp;</p><p dir="RTL">نظرًا إلى عدم معرفة إمكانية إفراز دواء إيرين في لبن الأم من عدمها، فيجب عليكِ تجنب الرضاعة الطبيعية بعد إجراء عملية جراحية إذا تم إعطاؤك إيرين كمخدر عام.</p><p dir="RTL">&nbsp;</p><p dir="RTL">استشيري الطبيب أو الجراح أو طبيب التخدير إذا كنتِ حاملاً أو يحتمل أن تكوني حاملاً أو إذا كنتِ مرضعة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">لا يسمح بالقيادة أو تشغيل أدوات أو آلات لفترة لا تقل عن 24 ساعة بعد العملية الجراحية في حالة تناول دواء إيرين. وإضافة إلى ذلك، قد يؤثر تناول المخدر في انتباهك وسلوكك، ما قد يؤثر في قدرتك على أداء المهام العادية لمدة تصل إلى 6 أيام. احرص على مرافقة شخص آخر عند العودة إلى المنزل بعد العملية الجراحية.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">سيتم إعطاؤك دواء إيرين &quot;دائمًا&quot; بواسطة طبيب تخدير. وهو من سيقرر الجرعة التي ستحصل عليها، وذلك بناء على عمرك ووزنك ونوع العملية الجراحية التي ستخضع لها.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تجب مراقبة طفلك عن قرب أثناء تناول الأيزوفلوران.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>تحفيز النوم في بداية التخدير </u></p><p dir="RTL">لا ينصح باستخدام الأيزوفلوران مع الرضع والأطفال لحثهم على النوم في بداية التخدير.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>الأدوية قبل التخدير</u></p><p dir="RTL">قد يقرر طبيب التخدير إعطاء طفلك دواءً لمواجهة الانخفاض المحتمل في التنفس وتأثيرات معدل ضربات القلب التي قد تحدث مع استخدام الأيزوفلوران.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يتم إنتاج إيرين من إيزوفلوران سائل في مُبخِّر. يمكن أن تتناول دواء إيرين بإحدى طريقتين:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يتم إعطاؤك حقنة مخدر آخر لتستغرق في النوم قبل إعطائك دواء إيرين من خلال قناع. وهذه هي الطريقة الأكثر شيوعًا التي قد تحصل بها على دواء إيرين.</p><p dir="RTL">أو</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يُطلب منك تنفس بخار الأيزوفلوران من خلال قناع حتى تستغرق في النوم. وسوف تستغرق في النوم بسرعة وسهولة. وهذه طريقة أقل شيوعًا للحصول على دواء إيرين.</p><p dir="RTL">&nbsp;</p><p dir="RTL">بعد إجراء العملية الجراحية، سيتوقف طبيب التخدير عن إعطائك دواء إيرين. عندئذٍ، سوف تستيقظ في غضون بضع دقائق.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا تم إعطاؤك كمية كبيرة للغاية من دواء إيرين </strong></p><p dir="RTL">إذا تم إعطاؤك كمية كبيرة من إيرين، فسيتم إيقاف الدواء. وسيتم إعطاؤك أكسجينًا نقيًا. كما سيتم فحص ضغط الدم ووظائف القلب بعناية أثناء التعافي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، يمكن أن يسبب هذا الدواء آثارًا جانبية، ومع ذلك لا تظهر على الجميع. ومعظم الآثار الجانبية خفيفة إلى معتدلة في شدتها وقصيرة ولكن قد يكون هناك بعض الآثار الجانبية الخطيرة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كنت تعاني أنت أو طفلك من أي أعراض غير عادية أو غير متوقعة بعد العملية، فأخبر طبيبك أو طبيب التخدير &quot;على الفور&quot;.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تشمل الآثار الجانبية الأكثر شيوعًا التي تم الإبلاغ عنها ما يلي:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تضيق في الرئتين والمسالك الهوائية يسبب صعوبة في التنفس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة مستويات السكر في الدم أو مستويات البوتاسيوم. وردت تقارير نادرة عن عدم انتظام ضربات القلب (اضطراب نظم القلب) والوفاة المرتبطة باستخدام الأدوية المخدرة التي يتم إعطاؤها بالاستنشاق عند الأطفال بعد العملية الجراحية بوقت قصير</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أخبر طبيبك أو الممرضة أو الصيدلي على الفور إذا لاحظت أيًا من الآثار الجانبية التالية، والتي يمكن أن تكون خطيرة.</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>غير معروفة (عدد الأشخاص المتأثرين غير معروف)</strong></p><ul><li dir="RTL">وجود مركّب كربوكسي هيموجلوبين في الدم</li><li dir="RTL">رد فعل تحسسي</li><li dir="RTL">فرط الحساسية</li><li dir="RTL">اضطرابات أو تغيرات في الحالة المزاجية، شديدة في بعض الأحيان</li><li dir="RTL">الارتباك والتشنجات والاعتلال الذهني</li><li dir="RTL">عدم انتظام ضربات القلب أو خفقان القلب</li><li dir="RTL">مخطط كهربية القلب غير الطبيعي (ECG)، تغير في معدل ضربات القلب أو نظم القلب</li><li dir="RTL">نوبة قلبية</li><li dir="RTL">انخفاض في ضغط الدم</li><li dir="RTL">نزف (نزيف غير منضبط)</li><li dir="RTL">التنفس السطحي البطيء</li><li dir="RTL">ضيق في التنفس والصفير</li><li dir="RTL">تشنج عضلي في الأحبال الصوتية (الحنجرة) يسمى تشنج الحنجرة.</li><li dir="RTL">تورم الوجه</li><li dir="RTL">التهاب الجلد التماسي</li><li dir="RTL">الطفح الجلدي</li><li dir="RTL">زيادة مستويات إنزيم في الدم يسمى الكرياتينين</li><li dir="RTL">انخفاض مستويات مادة في الدم تسمى اليوريا</li><li dir="RTL">يمكن أن تتوقف عضلات أمعائك عن العمل مؤقتًا، ما يسبب عدم الراحة والانتفاخ والقيء</li><li dir="RTL">الغثيان والقيء</li><li dir="RTL">عدم قدرة الكبد على العمل بشكل صحيح، بما في ذلك إصابة الكبد وموت خلايا الكبد</li><li dir="RTL">زيادة مستويات مادة في الدم تسمى البيليروبين</li><li dir="RTL">الارتجاف والشعور بالقشعريرة</li><li dir="RTL">ارتفاع درجة حرارة الجسم بسبب فرط الحرارة الخبيث</li><li dir="RTL">عدم ارتياح منطقة الصدر</li><li dir="RTL">مستويات غير طبيعية من خلايا أو منتجات محددة موجودة في دمك</li><li dir="RTL">زيادة مستويات فلوريد الدم (بسبب تحطيم الجسم لمادة الأيزوفلوران) نتائج غير طبيعية لاختبار مخطط كهربية الدماغ (EEG)</li><li dir="RTL">وجود الميوجلوبين (مادة من العضلات) في البول</li><li dir="RTL">تدمير العضلات</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الإبلاغ عن ردود الفعل السلبية المشتبه بها</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">في حالة تعرضك لأي آثار جانبية، تحدث إلى الطبيب أو الصيدلي أو الممرضة. يتضمن ذلك أي آثار جانبية محتملة غير مدرجة في هذه النشرة. يمكنك أيضًا الإبلاغ عن الآثار الجانبية مباشرةً عبر:</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp; </strong><strong>السعودية:</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:555px"><tbody><tr><td style="vertical-align:top"><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; المركز الوطني للتيقظ الدوائي:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مركز االتصال الموحد: 19999</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://ade.sfda.gov.sa/</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp; </strong><strong>دول الخليج العربي الأخرى:</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" style="width:556px"><tbody><tr><td><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; الرجاء الاتصال بالهيئة المختصة.</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL">بالإبلاغ عن الآثار الجانبية يمكنك المساعدة على توفير مزيد من المعلومات بشأن سلامة هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يخزن في درجة حرارة 30 درجة مئوية.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">يُحفظ بعيدًا عن متناول ورؤية الأطفال.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تستخدم إيرين بعد تاريخ انتهاء الصلاحية المدون على الغلاف. يشير تاريخ انتهاء الصلاحية إلى آخر يوم من الشهر المذكور.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تقم بالتخلص من أي أدوية في مياه الصرف الصحي أو في النفايات المنزلية. اسأل الصيدلي الخاص بك عن كيفية التخلص من الأدوية التي لم تعد تستخدمها. سوف تساعد هذه التدابير على حماية البيئة.&nbsp;</p><p dir="RTL"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>محتويات دواء إيرين</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">المادة الفعالة هي أيزوفلوران.</p><p dir="RTL">لا توجد مكونات أخرى.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>كيف يبدو دواء إيرين وما محتويات العبوة</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">يعد دواء إيرين مادة سائلة.</p><p dir="RTL">يتم توفيره في زجاجات سعة <strong>100</strong> ملم مزودة بغطاء لولبي للإغلاق.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>حامل ترخيص التسويق</strong></p><p dir="RTL"><strong>Baxter Healthcare Corporation </strong></p><p dir="RTL">Deerfield</p><p dir="RTL">IL 60015</p><p dir="RTL">USA</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>المصنع</strong></p><p><strong>Baxter Healthcare Corporation </strong></p><p>Route 3 Km 142.5</p><p>00784 Guayama</p><p>Puerto Rico</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            أكتوبر 2017
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AErrane Liquid for Inhalation
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each 100ml bottle AErrane contains 100ml isoflurane, USP
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Liquid for inhalation
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>AErrane is a volatile halogenated anaesthetic for general inhalation anaesthesia</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In order to be able to accurately control the precise concentration of isoflurane, vaporisers that have been specially calibrated for isoflurane should be used.</p><p>&nbsp;</p><p><strong>Induction of anaesthesia:</strong></p><p>If isoflurane is used for induction of anaesthesia, a starting concentration of 0.5% is recommended.&nbsp; Concentrations of 1.3-3.0% usually bring about surgical anaesthesia within 7 to 10 minutes.</p><p>It is recommended that use be made of a hypnotic dose of a short acting barbiturate or another product such as propofol, etomidate, or midazolam in order to avoid coughing or laryngospasms, which can arise if induction is carried out with AErrane alone or in combination with oxygen or with an oxygen-nitrous oxide mixture.</p><p>&nbsp;</p><p><strong>Maintenance of anaesthesia:</strong></p><p>Anaesthesia can be maintained during surgery using a concentration of 1.0-2.5% with the simultaneous administration of N<sub>2</sub>O and O<sub>2</sub>.</p><p>A higher concentration of 1.5-3.5% of AErrane is necessary if AErrane is administered with pure oxygen.</p><p>&nbsp;</p><p><strong>Recovery</strong></p><p>The concentration of AErrane must be reduced to 0.5% at the end of the operation, or to 0% during closure of the wound to allow prompt recovery.</p><p>If all administration of anaesthetic agents has been stopped, the air passages of the patient should be ventilated several times with 100% oxygen until complete awakening occurs.</p><p>If the vector gas is a mixture of 50% O<sub>2</sub> and 50% N<sub>2</sub>O, the value of the minimum alveolar concentration of isoflurane is approximately 0.65%.</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td colspan="3" style="vertical-align:top"><p><strong>ADULTS</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Age</strong></p></td><td style="vertical-align:top"><p><strong>Average MAC Value<br />in 100% Oxygen</strong></p></td><td style="vertical-align:top"><p><strong>70% N<sub>2</sub>O</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>26 &plusmn; 4 years</strong></p></td><td style="vertical-align:top"><p><strong>1.28%</strong></p></td><td style="vertical-align:top"><p><strong>0.56%</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>44 &plusmn; 7 years</strong></p></td><td style="vertical-align:top"><p><strong>1.15%</strong></p></td><td style="vertical-align:top"><p><strong>0.50%</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>64 &plusmn; 5 years</strong></p></td><td style="vertical-align:top"><p><strong>1.05%</strong></p></td><td style="vertical-align:top"><p><strong>0.37%</strong></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>PAEDIATRIC POPULATION</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Age</strong></p></td><td style="vertical-align:top"><p><strong>Average MAC Value<br />in 100% Oxygen</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Preterm neonates<br />&nbsp;&lt; 32 weeks gestational age</strong></p></td><td style="vertical-align:top"><p><strong>1.28%</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Preterm neonates<br />32-37 weeks gestational age</strong></p></td><td style="vertical-align:top"><p><strong>1.41%</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>0-1 month</strong></p></td><td style="vertical-align:top"><p><strong>1.60%</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>1-6 months</strong></p></td><td style="vertical-align:top"><p><strong>1.87%</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>6-12 months</strong></p></td><td style="vertical-align:top"><p><strong>1.80%</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>1-5 years</strong></p></td><td style="vertical-align:top"><p><strong>1.60%</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td></tr></tbody></table><p>&nbsp;</p><p><u>Premedication</u>:</p><p>Drugs used for premedication should be selected for the individual patient bearing in mind the respiratory depressant effect of isoflurane. The use of anticholinergic drugs is a matter of choice, but may be advisable for inhalation induction in paediatrics.</p><p>&nbsp;</p><p><u>Induction of anaesthesia in children</u>:</p><p>Isoflurane is not recommended for use as an inhalation induction agent in infants and children because of the occurrence of cough, breath-holding, desaturation, increased secretions and laryngospasm (see section 4.4).</p><p>ed anaesthetic for general inhalation anaesthesia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                •	Isoflurane is contraindicated in patients with known sensitivity to isoflurane or other halogenated anaesthetics.
•	It is also contraindicated in patients with known or suspected genetic susceptibility to malignant hyperthermia.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>As with any potent general anesthetic, isoflurane should only be administered in an adequately equipped anesthetizing environment by those who are familiar with the pharmacology of the drug and qualified by training and experience to manage the anesthetized patient.</p><p>Vaporizers specially calibrated for isoflurane should be used so that the concentration of anesthetic delivered can be accurately controlled.</p><p>Hypotension and respiratory depression increase as anesthesia is deepened.</p><p>Since levels of anesthesia may be altered quickly and easily with isoflurane, only vaporizers which deliver a predictable output with reasonable accuracy, or techniques during which inspired or expired concentrations can be monitored, should be used. The degree of hypotension and respiratory depression may provide some indication of anesthetic depth.</p><p>Reports of QT prolongation, associated with torsade de pointes (in exceptional cases, fatal) have been received. Caution should be exercised when administering isoflurane to patients at risk for QT prolongation.</p><p>&nbsp;</p><p>Caution should be exercised in administering general anesthesia, including isoflurane, to patients with mitochondrial disorders.</p><p>Reports demonstrate that isoflurane can produce hepatic injury ranging from mild transient increases of liver enzymes to fatal hepatic necrosis in very rare instances.</p><p>&nbsp;</p><p>It has been reported that previous exposure to halogenated hydrocarbon anesthetics, especially if the interval is less than 3 months, may increase the potential for hepatic injury.</p><p>Cirrhosis, viral hepatitis, or other pre-existing liver disease can be a reason to select an anaesthetic other than a halogenated anaesthetic.</p><p>Isoflurane may cause respiratory depression which may be augmented by narcotic premedication or other agents causing respiratory depression. Respiration should be supervised and if necessary, assisted (see section 4.8).</p><p>Relatively little metabolism of isoflurane occurs in the human body.&nbsp; In the post operative period only 0.17% of the isoflurane taken up can be recovered as urinary metabolites.&nbsp; Peak serum inorganic fluoride values usually average less than 5 micromol/litre and occur about four hours after anaesthesia, returning to normal levels within 24 hours.&nbsp; No signs of renal injury have been reported after isoflurane administration.</p><p>&nbsp;</p><p>There is insufficient experience of use in repeated anaesthesia to make a definitive recommendation in this regard.&nbsp; As with all halogenated anaesthetics repeat anaesthesia within a short period of time should be approached with caution.</p><p>&nbsp;</p><p>A potentiation of neuromuscular fatigue can be seen in patients with neuromuscular diseases, such as myasthenia gravis. Isoflurane should be used with caution in these patients Isoflurane markedly increases cerebral blood flow at deeper levels of anesthesia. There may be a transient rise in cerebral spinal fluid pressure which is fully reversible with hyperventilation.&nbsp;</p><p>&nbsp;</p><p>Isoflurane must be used with caution in patients with increased intracranial pressure. In such cases hyperventilation may be necessary AErrane should be administered with caution to patients who can develop bronchoconstriction since bronchospasms can occur (see section 4.8).</p><p>&nbsp;</p><p>Use of isoflurane in hypovolemic, hypotensive and debilitated patients has not been extensively investigated. A lower concentration of isoflurane is recommended for use in these patients.</p><p>&nbsp;</p><p>Regardless of the anesthetics employed, maintenance of normal hemodynamics is important to the avoidance of myocardial ischemia in patients with coronary artery disease.</p><p>&nbsp;</p><p>In light of the fact that AErrane acts in an irritating manner on the mucous membranes, the product is difficult to use if inhalation anaesthesia is applied via mask.&nbsp; During the induction of anaesthesia in children, saliva flow and tracheobronchial secretion can increase and can be the cause of laryngospasms, particularly in children (see section 4.8).</p><p>&nbsp;</p><p>Increased blood losses comparable with those found following anaesthesia with other inhalation agents have been recorded with isoflurane in patients undergoing induced abortion.</p><p>&nbsp;</p><p>Isoflurane relaxes the uterus muscle, and the lowest possible concentration of isoflurane should be used in obstetrical operations (Please refer to section 4.6).</p><p>&nbsp;</p><p><strong><em>Malignant Hyperthermia</em></strong></p><p>In susceptible individuals, isoflurane anesthesia may trigger a skeletal muscle hypermetabolic state leading to high oxygen demand and the clinical syndrome known as malignant hyperthermia. The syndrome includes nonspecific features such as muscle rigidity, tachycardia, tachypnea, cyanosis, arrhythmias, and unstable blood pressures. (It should also be noted that many of these nonspecific signs may appear with light anesthesia, acute hypoxia, etc.)&nbsp; An increase in overall metabolism may be reflected in an elevated temperature (which may rise rapidly early or late in the case, but usually is not the first sign of augmented metabolism) and an increased usage of the CO<sub>2</sub> absorption system (hot canister). PaO<sub>2</sub> and pH may decrease, and hyperkalemia and a base deficit may appear. Fatal outcome of malignant hyperthermia has been reported with isoflurane. Treatment includes discontinuance of triggering agents (e.g. isoflurane), intravenous administration of dantrolene sodium, and application of supportive therapy. Such therapy includes vigorous efforts to restore body temperature to normal, respiratory and circulatory support as indicated, and management of electrolyte-fluid-acid-base derangements. (Consult prescribing information for dantrolene sodium intravenous for additional information on patient management.) Renal failure may appear later.</p><p>&nbsp;</p><p>Isolated cases of increased carboxyhemoglobin have been reported with the use of halogenated inhalation agents with a -CF<sub>2</sub>H moiety (i.e., desflurane, enflurane and isoflurane). No clinically significant concentrations of carbon monoxide are produced in the presence of normally hydrated absorbents. Care should be taken to follow manufacturers&#39; instructions for CO<sub>2</sub> absorbents.</p><p>&nbsp;</p><p>Rare cases of extreme heat, smoke and/or spontaneous fire in the anesthesia machine have been reported during administration of general anesthesia with drugs in this class when used in conjunction with desiccated CO2 absorbents, specifically those containing potassium hydroxide (e.g. Baralyme).&nbsp; When a clinician suspects that the CO2 absorbent may be desiccated, it should be replaced before administration of isoflurane.&nbsp; The color indicator of most CO2 absorbents does not necessarily change as a result of desiccation.&nbsp; Therefore, the lack of significant color change should not be taken as an assurance of adequate hydration.&nbsp; CO2 absorbents should be replaced routinely regardless of the state of the color indicator.</p><p>&nbsp;</p><p><strong>Perioperative Hyperkalaemia:</strong></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Use of inhaled anaesthetic agents has been associated with rare increases in serum potassium levels that have resulted in cardiac arrhythmias and death in paediatric patients during the postoperative period.&nbsp; Patients with latent as well as overt neuromuscular disease, particularly Duchenne muscular dystrophy, appear to be most vulnerable. Concomitant use of succinylcholine has been associated with most, but not all of these cases. These patients also experienced significant elevations in serum creatine kinase levels and, in some cases, changes in urine consistent with myoglobinuria. Despite the similarity in presentation to malignant hyperthermia, none of these patients exhibited signs or symptoms of muscle rigidity or hypermetabolic state. Early and aggressive intervention to treat the hyperkalaemia and resistant arrhythmias is recommended, as is subsequent evaluation for latent neuromuscular disease.</p><p>&nbsp;</p><p>Isoflurane may cause a slight decrease in intellectual function for 2-4 days following anesthesia. Small changes in moods and symptoms may persist for up to 6 days after administration. This must be taken into account when patients resume normal daily activities, including driving or operating heavy machinery (please refer to section 4.7).</p><p>&nbsp;</p><p>All commonly used muscle relaxants are markedly potentiated by isoflurane, the effect being most profound with non-depolarizing agents.</p><p>&nbsp;</p><p>During the induction of anesthesia, saliva flow and thracheobronchial secretion can increase and can be the cause of laryngospasm, particularly in children (see section 4.8).</p><p>&nbsp;</p><p><strong>Children Under Two Years of Age</strong></p><p>Caution should be exercised when isoflurane is used in small children due to limited experience with this patient-group.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The simultaneous administration of isoflurane and the following products requires strict supervision of the clinical and biological condition of the patient;</p><p>&nbsp;</p><p><strong>Combinations advised against:</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Beta-sympathomimetics (isoprenaline) and alpha- and beta- sympathomimetics (epinephrine &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or adrenaline; norepinephrine or noradrenaline): should be used with caution during isoflurane narcosis, due to a potential risk of ventricular arrhythmia</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nonselective MAOI: Risk of crisis and hemodynamic instability during the surgery or medical procedures. Treatment should be stopped 15 days prior to surgery.</p><p>&nbsp;</p><p><strong>Combinations requiring precautions in using:</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Beta-blockers:&nbsp; Concomitant use of beta blockers may exaggerate the cardiovascular effects of inhalational anesthetics, including hypotension and negative inotropic effects. Risk of blockage of the cardiovascular compensation mechanism, as a result of which negative inotropic effects are intensified.&nbsp; The action of beta-blockers can be suppressed during the operation with the use of beta-sympathomimetic agents.&nbsp; In general, any medication with a beta-blocker need not be stopped and an abrupt reduction of the dosage should be avoided.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Isoniazid: risk of potentiating the hepatotoxic effect, with increased formation of toxic metabolites of isoniazid.&nbsp; Treatment with isoniazid should be suspended one week before the operation and should not be resumed until 15 days afterwards.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Epinephrine (adrenaline) by sub-cutaneous or gingival injections: risk of serious ventricular arrhythmia as a consequence of increased heart &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rate, although the myocardial sensitivity with respect to epinephrine is lower with the use of isoflurane than in the case of halothane.&nbsp; Thus, the dosage should be limited to, for example, 0.1 mg epinephrine within 10 minutes or 0.3 mg within one hour in adults. Doses of adrenaline greater than 5 mcg/kg, when administered submucosally, may produce multiple ventricular arrhythmias.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Indirect-acting sympathomimetics (amphetamines and their derivatives; psychostimulants, appetite suppressants, ephedrine and its derivatives): risk of perioperative hypertension.&nbsp; In patients undergoing elective surgery, treatment should ideally be discontinued several days before surgery.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In the majority of cases where a drug treatment is indispensable, there is no reason to suspend it before general anaesthesia.&nbsp; It suffices to inform the anaesthetist about it.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; All commonly used muscle relaxants are markedly potentiated by isoflurane, the effect being most profound with non-depolarizing agents&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Thus it is recommended that approximately one third to one half of the usual dose of these substances be administered.&nbsp; The disappearance of the myoneural effect takes longer with isoflurane than with other conventional anaesthetics.&nbsp; Neostigmine has an effect on the non-depolarising relaxants, but has no effect on the relaxing action of isoflurane itself.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Opioids, benzodiazepines and other sedative agents are associated with respiratory depression, and caution should be exercised when concomitantly administered with isoflurane.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Calcium antagonists: isoflurane may lead to marked hypotension in patients treated with calcium antagonists, particularly dihydropyridine derivatives. Caution should be exercised when calcium antagonists are used concomitantly with inhalation anaesthetics due to the risk of additive negative inotropic effect.</p><p>&nbsp;</p><p>MAC (minimum alveolar concentration) is reduced by concomitant administration of N20 in adults (see section 4.2)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Use in Pregnancy</strong></p><p>There are no or limited amount of data from the use of isoflurane in pregnant women. Studies in animals have shown reproductive toxicity. Isoflurane should only be used during pregnancy if the benefit outweighs the potential risk. (see section 5.3)</p><p>Isoflurane relaxes the uterus muscle, and the lowest possible concentration of isoflurane should be used in obstetrical operations.</p><p><strong>Use in Caesarean Section</strong></p><p>Isoflurane, in concentrations up to 0.75%, has been shown to be safe for the maintenance of anesthesia for cesarean section (please refer to section 4.4).</p><p><strong>Nursing&nbsp;Mothers</strong></p><p>It is not known whether isoflurane/metabolites are excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when isoflurane is administered to a nursing woman.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The medicinal product can have influence on driving and using machines. The patient should not drive or use machines for at least 24 hours after anaesthesia with isoflurane. Changes in behaviour and intellectual function may persist for up to 6 days after administration. This must be taken into account when patients resume normal daily activities, including driving or operating heavy machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em>a. Summary of the safety profile</em></strong></p><p>Adverse reactions encountered in the administration of isoflurane are in general dose dependent extensions of pharmacophysiologic effects and include respiratory depression, hypotension and arrhythmias.&nbsp; Potential serious undesirable effects include malignant hyperthermia, anaphylactic reactions and liver adverse reactions (please refer to section 4.4 and 4.8). Shivering, nausea, vomiting and ileus have been observed in the postoperative period.</p><p>Cardiac arrest has been observed with general inhalation anesthetic drugs including isoflurane.</p><p><strong><em>&nbsp;</em></strong></p><p><strong><em>b. Tabulated summary of adverse reactions</em></strong></p><p>The following table displays adverse reactions reported in clinical trials and from post-marketing experience.&nbsp; Frequency cannot be estimated from the available data, therefore it is &ldquo;not known&rdquo;.</p><p><strong><em>&nbsp;</em></strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td colspan="3" style="vertical-align:top"><p><strong>Summary of Most Frequent Adverse Drug Reactions</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>SOC</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td><td style="vertical-align:top"><p><strong>Adverse Reactions</strong></p></td></tr><tr><td style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Carboxyhaemoglobinaemia<sup>2</sup></p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Immune system disorders</p></td><td rowspan="2" style="vertical-align:top"><p>Not known</p><p>Not known</p></td><td style="vertical-align:top"><p>Anaphylactic reaction<sup>1</sup></p></td></tr><tr><td style="vertical-align:top"><p>Hypersensitivity<sup>1</sup></p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Metabolsim and nutrition disorders</p></td><td rowspan="2" style="vertical-align:top"><p>Not known</p><p>Not known</p></td><td style="vertical-align:top"><p>Hyperkalaemia<sup>2</sup></p></td></tr><tr><td style="vertical-align:top"><p>Blood glucose increased</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>Psychiatric disorders</p></td><td rowspan="3" style="vertical-align:top"><p>Not known</p><p>Not known</p><p>Not known</p></td><td style="vertical-align:top"><p>Agitation</p></td></tr><tr><td style="vertical-align:top"><p>Delirium</p></td></tr><tr><td style="vertical-align:top"><p>Mood altered<sup>5</sup></p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Nervous system disorders</p></td><td rowspan="2" style="vertical-align:top"><p>Not known</p><p>Not known</p></td><td style="vertical-align:top"><p>Convulsion</p></td></tr><tr><td style="vertical-align:top"><p>Mental impairment<sup>4</sup></p></td></tr><tr><td rowspan="6" style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Arrhythmia</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Bradycardia</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Cardiac arrest</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Electrocardiogram QT prolonged</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Tachycardia</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Torsade de pointes</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Vascular disorders</p></td><td rowspan="2" style="vertical-align:top"><p>Not known</p><p>Not known</p></td><td style="vertical-align:top"><p>Hypotension<sup>2</sup></p></td></tr><tr><td style="vertical-align:top"><p>Haemorrhage<sup>3</sup></p></td></tr><tr><td rowspan="5" style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td rowspan="5" style="vertical-align:top"><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p></td><td style="vertical-align:top"><p>Bronchospasm<sup>2</sup></p></td></tr><tr><td style="vertical-align:top"><p>Dyspnoea<sup>1</sup></p></td></tr><tr><td style="vertical-align:top"><p>Wheezing<sup>1</sup></p></td></tr><tr><td style="vertical-align:top"><p>Respiratory depression<sup>2</sup></p></td></tr><tr><td style="vertical-align:top"><p>Laryngospasm<sup>2</sup></p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td rowspan="3" style="vertical-align:top"><p>Not known</p><p>Not known</p><p>Not known</p></td><td style="vertical-align:top"><p>Ileus</p></td></tr><tr><td style="vertical-align:top"><p>Vomiting</p></td></tr><tr><td style="vertical-align:top"><p>Nausea</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>Hepatobiliary disorders</p></td><td rowspan="3" style="vertical-align:top"><p>Not known</p><p>Not known</p><p>Not known</p></td><td style="vertical-align:top"><p>Hepatic necrosis<sup>2</sup></p></td></tr><tr><td style="vertical-align:top"><p>Hepatocellular injury<sup>2</sup></p></td></tr><tr><td style="vertical-align:top"><p>Blood bilirubin increased.</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td rowspan="3" style="vertical-align:top"><p>Not known</p><p>Not known</p><p>Not known</p></td><td style="vertical-align:top"><p>Swelling face<sup>1</sup></p></td></tr><tr><td style="vertical-align:top"><p>Dermatitis contact<sup>1</sup></p></td></tr><tr><td style="vertical-align:top"><p>Rash<sup>1</sup></p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Renal and urinary disorders</p></td><td rowspan="2" style="vertical-align:top"><p>Not known</p><p>Not known</p></td><td style="vertical-align:top"><p>Blood creatinine increased</p></td></tr><tr><td style="vertical-align:top"><p>Blood urea decreased</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td rowspan="3" style="vertical-align:top"><p>Not known</p><p>Not known</p><p>Not known</p></td><td style="vertical-align:top"><p>Hyperthermia malignant<sup>2</sup></p></td></tr><tr><td style="vertical-align:top"><p>Chest discomfort<sup>1</sup></p></td></tr><tr><td style="vertical-align:top"><p>Chills</p></td></tr><tr><td rowspan="7" style="vertical-align:top"><p>Investigations</p></td><td rowspan="6" style="vertical-align:top"><p>Not known</p><p>&nbsp;</p><p>Not known</p><p>Not known</p><p>Not known</p><p>&nbsp;</p><p>Not known</p><p>Not known</p></td><td style="vertical-align:top"><p>White blood cell count increased<sup>1</sup></p></td></tr><tr><td style="vertical-align:top"><p>Hepatic enzyme increased<sup>2</sup></p></td></tr><tr><td style="vertical-align:top"><p>Fluoride increased<sup>1</sup></p></td></tr><tr><td style="vertical-align:top"><p>Electroencephalogram abnormal</p></td></tr><tr><td style="vertical-align:top"><p>Blood cholesterol decreased</p></td></tr><tr><td style="vertical-align:top"><p>Blood alkaline phosphatase decreased</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Blood creatine phosphokinase increased</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Myoglobinuria</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Rhabdomyolysis</p></td></tr></tbody></table><p><sup>1</sup>See 4.8(c)</p><p><sup>2</sup>See 4.4</p><p><sup>3</sup>In patients undergoing induced abortion. See 4.4.</p><p><sup>4</sup>May cause a slight decrease in intellectual function for 2-4 days after anesthesia.&nbsp; See 4.4.</p><p><sup>5</sup>Small changes in moods and symptoms may persist for up to 6 days. See 4.4.</p><p>&nbsp;</p><p><strong><em>c. Description of selected adverse reactions</em></strong></p><p>&nbsp;Transient elevations in white blood count have been observed even in the absence of surgical stress.</p><p>Rare reports of hypersensitivity (including dermatitis contact, rash, dyspnoea, wheezing, chest discomfort, swelling face, or anaphylactic reaction) have been received, especially in association with long-term occupational exposure to inhaled anesthetic agents, including isoflurane.&nbsp; These reactions have been confirmed by clinical testing (e.g., methacholine challenge). The etiology of anaphylactic reactions experienced during inhalational anesthetic exposure is, however, unclear because of the exposure to multiple concomitant drugs, many of which are known to cause such reactions.</p><p>Minimally raised levels of serum inorganic fluoride occur during and after isoflurane anesthesia, due to biodegradation of the agent.&nbsp; It is unlikely that the low levels of serum inorganic fluoride observed (mean 4.4 &micro;mol/l in one study) could cause renal toxicity, as these are well below the proposed threshold levels for kidney toxicity.</p><p>&nbsp;</p><p><strong><em>d. Paediatric population</em></strong></p><p><strong><em>&nbsp;</em></strong>Use of inhaled anesthetic agents has been associated with rare increases in serum potassium levels that have resulted in cardiac arrhythmias and death in pediatric patients during the postoperative period. (See 4.4.)</p><p>During the induction of anesthesia, saliva flow and tracheobronchial secretion can increase and can be the cause of laryngospasm. (See 4.4.)</p><p><strong><em>&nbsp;</em></strong></p><p><strong><em>e. Other special populations</em></strong></p><p><strong><em>&nbsp;</em></strong><strong>Neuromuscular disease:</strong></p><p>Use of inhaled anesthetic agents has been associated with rare increases in serum potassium levels that have resulted in cardiac arrhythmias and death in pediatric patients during the postoperative period. Patients with latent as well as overt neuromuscular disease, particularly Duchenne muscular dystrophy, appear to be most vulnerable. Early and aggressive intervention to treat the hyperkalaemia and resistant arrhythmias is recommended, as is subsequent evaluation for latent neuromuscular disease (See 4.4.)</p><p><strong>Elderly:</strong></p><p>Lesser concentrations of isoflurane are normally required to maintain surgical anesthesia in elderly patients. (See 4.2.)</p><p>&nbsp;</p><p><strong>Reporting of suspected adverse reactions</strong></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It&nbsp;allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via:</p><p>&middot;&nbsp;&nbsp;&nbsp; Saudi Arabia:</p><table border="1" cellspacing="0" cellpadding="0" style="width:595px"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance Centre (NPC)</p><p>- SFDA Call Center: 19999</p><p>- E-mail: npc.drug@sfda.gov.sa</p><p>- Website: https://ade.sfda.gov.sa/<u> </u>&nbsp;</p></td></tr></tbody></table><p>&middot;&nbsp;&nbsp;&nbsp; Other GCC States:</p><table border="1" cellspacing="0" cellpadding="0" style="width:595px"><tbody><tr><td><p>-&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In case of overdosage, stop administration of the anaesthetic agent.</p><p>Hypotension and respiratory depression have been observed.&nbsp; Close monitoring of blood pressure and respiration is recommended. Supportive measures may be necessary to correct hypotension and respiratory depression resulting from excessively deep levels of anaesthesia. Check whether air passages are open, and depending on the circumstances, continue with assisted or controlled respiration using pure oxygen.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmaco-therapeutic group:</strong> Anaesthetics, general</p><p><strong>ATC code: </strong>N01AB06</p><p>Isoflurane is an inhalation-type anaesthetic, belonging to the group of halogenated anaesthetics.&nbsp; Induction and recovery from anaesthesia take place rapidly with isoflurane.</p><p>Isoflurane has the slightly irritating odour of ether, which can limit the speed of induction.</p><p>Pharyngeal and laryngeal reflexes are rapidly diminished as a result of which tracheal intubation is rendered easy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>AErrane is metabolised minimally in comparison to other halogenated anaesthetics.&nbsp; On average 95% of the AErrane is recovered in the expired air; 0.2% of the AErrane that is taken up within the body is metabolised.&nbsp; The principal metabolite is trifluoroacetic acid.&nbsp; The average serum level of inorganic fluoride in patients administered AErrane anaesthesia is between 3 and 4 micromol/litre.</p><p>In patients anaesthetised with isoflurane, the mean serum concentration of inorganic fluorides is usually less than 5 micromol/litre and occurs about four hours after anaesthesia, returning to normal levels within 24 hours.&nbsp; This should not alter renal function in a normal subject.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Published studies in animals (including primates) at doses resulting in light to moderate anaesthesia demonstrate that the use of anaesthetic agents during the period of rapid brain growth or synaptogenesis results in cell loss in the developing brain that can be associated with prolonged cognitive deficiencies. The clinical significance of these nonclinical findings in not known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>AErrane is supplied in 100 ml bottles with screw cap closures.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>See under section 4.2, Posology and Method of Administration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Baxter Healthcare Corporation
Deerfield
IL 60015
USA
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                January 2019
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>